Tag Cloud Results
Results found matching tag initiates
From the News
AMI Research Initiates Coverage on Diagnostic Imaging International Corp. With a Speculative Buy Rating ...
Venaxis Initiates Patient Enrollment for APPY1 Pivotal Study
UK initiates first cancer reporting model of its kind in US
Wm Smith Research Initiates Coverage of Nymox
Abbott Initiates International ABSORB BTK Clinical Trial for Treatment of Below-the-Knee Critical Limb ...
Basilea initiates multiple ascending dose phase I study with novel antibiotic BAL30072 active against ...
Basilea initiates first-in-human study with its novel anti-cancer drug BAL101553
Clariant initiates squeeze-out process for Süd-Chemie
Infinity Initiates Randomized Phase 2 Trial of IPI-504 in Non-Small Cell Lung Cancer
Life Technologies initiates clinical trials leading to 510(k) submission of a class I and class II HLA ...
Infinity Initiates Phase 2 Trial of IPI-926 in Patients With Chondrosarcoma
Infinity Initiates Phase 2 Portion of Trial of IPI-926 in Pancreatic Cancer
McNeil Consumer Healthcare initiates voluntary recall of certain Over-The-Counter (OTC) products
Bayer initiates Phase III trial of Regorafenib in metastatic or unresectable gastrointestinal stromal ...
From the News
AMI Research Initiates Coverage on Diagnostic Imaging International Corp. With a Speculative Buy Rating ...
Venaxis Initiates Patient Enrollment for APPY1 Pivotal Study
UK initiates first cancer reporting model of its kind in US
Wm Smith Research Initiates Coverage of Nymox
Abbott Initiates International ABSORB BTK Clinical Trial for Treatment of Below-the-Knee Critical Limb ...
Basilea initiates multiple ascending dose phase I study with novel antibiotic BAL30072 active against ...
Basilea initiates first-in-human study with its novel anti-cancer drug BAL101553
Clariant initiates squeeze-out process for Süd-Chemie
Infinity Initiates Randomized Phase 2 Trial of IPI-504 in Non-Small Cell Lung Cancer
Life Technologies initiates clinical trials leading to 510(k) submission of a class I and class II HLA ...
Infinity Initiates Phase 2 Trial of IPI-926 in Patients With Chondrosarcoma
Infinity Initiates Phase 2 Portion of Trial of IPI-926 in Pancreatic Cancer
McNeil Consumer Healthcare initiates voluntary recall of certain Over-The-Counter (OTC) products
Bayer initiates Phase III trial of Regorafenib in metastatic or unresectable gastrointestinal stromal ...
Social Media
Contact
BioValley
Contact Form
Leonhard E. Loew
BioValley Basel Association
Aeschenvorstadt 57
CH-4051 Basel / Switzerland
Tel. +41 61 271 59 30
info(at)biovalley.ch
Contact Form
Leonhard E. Loew
BioValley Basel Association
Aeschenvorstadt 57
CH-4051 Basel / Switzerland
Tel. +41 61 271 59 30
info(at)biovalley.ch
Impressum
Copyright © 2013 by i-net innovation networks switzerland & BioValley | Concept & Design by Neko | Code and Hosting by Simplicity
